GlaxoSmithKline

GSK Acquires Okairos AG for €250 million

As per recent reports, it has been revealed that GlaxoSmithKline (GSK) has acquired Okairos AG for _250 million. By making such a move, the company has strengthened its vaccine business, said experts.

Experts continued by affirming that the recent acquisition of Okairos AG clearly shows that GSK wants to progress further in developing innovative medicines.

GSK and Vodafone Enter New Alliance to Boost Vaccines Uptake in Africa

GlaxoSmithKline has decided a new target with Vodafone: to boost the uptake of childhood vaccinations in Africa with the help of some new innovative mobile technologies.

GSK’s Expansion plans in Indian and Nigerian Markets

GlaxoSmithKline PLC, which is considered to be U. K.'s largest drug maker in terms of sales, has shown its interest in expanding its operation in India and Nigeria.

GSK makes impressive HIV/AIDS treatment

As compared to Gilead’s drug Atripla that is leading the market, a drug from GlaxoSmithKline and its Japanese partner Shionogi has proved better. It is once daily drug and it went through a late-stage clinical trial.

Barbie Sales declined 21% in 3rd Quarter

Unemployment Rate slightly down in Ohio

You can get $10 if you have been purchasing Red Bull Since 2002

RBS Subsidiary offers Second Largest US IPO in 2014

Barnes & Noble reports smaller first-quarter loss

AustrianTribune Specials

New monkey discovered at Tibet

A team of experts have discovered a new species of macaque in the Tibetan state of Modog and they are distinguishable from the other four kinds of macaque because of its penis. The new spcies is called Macacaleucogenys or the 'white-cheeked...